Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 189,030,992
  • Shares Outstanding, K 5,554,834
  • Annual Sales, $ 51,750 M
  • Annual Income, $ 16,273 M
  • 60-Month Beta 0.68
  • Price/Sales 3.70
  • Price/Cash Flow 8.40
  • Price/Book 2.93

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.64
  • Number of Estimates 3
  • High Estimate 0.73
  • Low Estimate 0.55
  • Prior Year 0.80
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.61 +6.93%
on 06/26/20
36.66 -7.80%
on 06/09/20
-2.79 (-7.63%)
since 06/08/20
3-Month
31.61 +6.93%
on 06/26/20
39.22 -13.82%
on 04/28/20
-0.80 (-2.31%)
since 04/08/20
52-Week
27.88 +21.23%
on 03/23/20
44.10 -23.36%
on 07/10/19
-9.50 (-21.94%)
since 07/08/19

Most Recent Stories

More News
AstraZeneca's Lynparza Gets EU Nod for Pancreatic Cancer

AstraZeneca (AZN) and Merck's Lynparza gets approval in the EU for treating patients with germline BRCA-mutated metastatic pancreatic cancer.

AZN : 54.19 (+1.35%)
PFE : 33.80 (-0.68%)
MRK : 77.92 (-1.02%)
GSK : 40.73 (+0.87%)
Pfizer (PFE) Dips More Than Broader Markets: What You Should Know

Pfizer (PFE) closed the most recent trading day at $34.03, moving -1.39% from the previous trading session.

PFE : 33.80 (-0.68%)
Next Support Level for Pfizer Inc (PFE) is $34.02

Shares of Pfizer Inc (NYSE:PFE) have bearishly opened below the pivot of $34.63 today and have reached the first support level of $34.26. Analysts will be watching for a cross of the next downside pivot...

PFE : 33.80 (-0.68%)
New Innovative Brands Look to Disrupt big Tobacco With Better-for-you Alternatives

, /PRNewswire/ -- Tobacco use has continued to grow steadily since its humble beginnings, fueled by the mass marketing of cigarettes in the 20th century. Nowadays, however, the tobacco industry's growth...

JNJ : 143.27 (+0.29%)
BTI : 38.81 (-0.94%)
PFE : 33.80 (-0.68%)
GSK : 40.73 (+0.87%)
TAAT.CN : 0.930 (-1.06%)
Is it the Right Time to Invest in Momentum ETFs? Let's Explore

Here we discuss whether it will be wise to invest in momentum ETFs now as the U.S. manufacturing is showing signs of recovery along with improvements in the jobs market.

PFE : 33.80 (-0.68%)
PDP : 69.81 (+1.32%)
ONEO : 68.78 (+0.43%)
MTUM : 137.70 (+1.15%)
ULVM : 45.59 (+0.38%)
XMMO : 59.98 (+0.96%)
3 Diverse Stocks to Buy Now for Second Half Coronavirus Immunity & Growth

A look at three stocks from completely different economic sectors that are poised to grow during the second half of 2020, despite continued coronavirus economic uncertainty...

TGT : 117.70 (-0.30%)
AMZN : 3,081.11 (+2.70%)
PFE : 33.80 (-0.68%)
WMT : 125.48 (-1.16%)
DG : 186.53 (-0.69%)
LLY : 169.13 (+1.43%)
NFLX : 502.78 (+1.95%)
TSLA : 1,365.88 (-1.73%)
ABBV : 99.52 (+0.17%)
ZM : 266.32 (+1.61%)
Moderna Shares Lose Momentum After Meteoric Rise: Here's Why

The encouraging progress with mRNA-based coronavirus vaccine drives meteoric rise in Moderna's (MRNA) shares. However, a rumored concern leads to correction.

JNJ : 143.27 (+0.29%)
SNY : 51.52 (+0.17%)
PFE : 33.80 (-0.68%)
MRNA : 61.58 (+0.80%)
Regulators Move to Remove Restriction on Some Uses of Psilocybin

, /PRNewswire/ -- The political push for the legalization of psychedelic products is now underway. Earlier this week, an ballot measure to legalize the use of psilocybin, a naturally occurring psychedelic...

APHA : 4.31 (-0.46%)
ZYNE : 3.42 (+5.23%)
MYCOF : 0.6600 (+10.00%)
MYCO.CN : 0.890 (+7.23%)
NVS : 88.12 (+0.36%)
PFE : 33.80 (-0.68%)
APHA.TO : 5.81 (-0.85%)
Mission Raises $15m and Expands its Relationship with Pfizer

Mission Therapeutics ("Mission"), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that it has raised $15m (�12m) in equity...

PFE : 33.80 (-0.68%)
Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

JNJ : 143.27 (+0.29%)
AZN : 54.19 (+1.35%)
PFE : 33.80 (-0.68%)
MRNA : 61.58 (+0.80%)
IBB : 140.81 (+0.54%)
XBI : 116.77 (+1.50%)
BBH : 168.10 (+0.48%)
FBT : 174.53 (+0.90%)
ARKG : 57.63 (+2.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PFE with:

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 34.71
1st Resistance Point 34.26
Last Price 33.80
1st Support Level 33.46
2nd Support Level 33.11

See More

52-Week High 44.10
Fibonacci 61.8% 37.91
Fibonacci 50% 35.99
Fibonacci 38.2% 34.08
Last Price 33.80
52-Week Low 27.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar